| Ray Green, MD | |
|
1 Hospital Road North, Belcourt, ND 58316 | |
| (701) 477-6111 | |
| (701) 477-6111 |
| Full Name | Ray Green |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1 Hospital Road North, Belcourt, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164495727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 17969 (North Carolina) | Primary |
| 207V00000X | Obstetrics & Gynecology | 015377 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ray Green, MD 1 Hospital Road North, Belcourt, ND 58316 Ph: (701) 477-6111 | Ray Green, MD 1 Hospital Road North, Belcourt, ND 58316 Ph: (701) 477-6111 |
News Archive
When a medical imaging exam provides a clinical benefit, the only risk that should be considered is the exam itself rather than a patient's previous radiation exposure, according to a statement by three scientific groups representing medical physicists, radiologists, and health physicists.
MAP Pharmaceuticals, Inc. today announced that LEVADEX orally inhaled migraine drug will be featured in four poster presentations, including one late-breaker presentation, at the 15th Congress of the International Headache Society (IHC) in Berlin, Germany on June 23-26, 2011.
Detroit Medical Center (DMC) officials today made good on their promise to get right to work on hospital construction projects, announcing contracts totaling over $60 million just four days after DMC's landmark partnership with Vanguard Health Systems was sealed.
Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation as a development candidate of a drug to treat an undisclosed rare and serious disease. Isis will develop the drug to Phase 2 proof-of-concept, at which time GSK has the option to license it.
Reports suggest that at least 25% of ovarian disorders are due to dysfunction of the brain mechanism in the hypothalamus that controls the gonadotropin-releasing hormone (GnRH), which is a molecule that governs the reproductive function in men and women by regulating the release of a range of reproductive hormones into the body, particularly gonadotropins, from the pituitary gland, which is located underneath the brain.
› Verified 9 days ago
Pamela Kidd, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Road, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-8410 | |
Manh Van Pham, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1300 Hospital Loop, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-2057 |